Home spirometry for idiopathic pulmonary fibrosis: ready for prime time?

Toby M Maher^{1

2}

Affiliations

¹ NIHR Respiratory Biomedical Research Unit, Royal Brompton Hospital, London, UK t.maher@imperial.ac.uk.
² Fibrosis Research Group, National Heart and Lung Institute, Imperial College, London, UK.

Free article

Editorial

Toby M Maher. Eur Respir J. 2017.

Free article

. 2017 Jul 20;50(1):1701403.

doi: 10.1183/13993003.01403-2017. Print 2017 Jul.

Toby M Maher^{1

2}

¹ NIHR Respiratory Biomedical Research Unit, Royal Brompton Hospital, London, UK t.maher@imperial.ac.uk.
² Fibrosis Research Group, National Heart and Lung Institute, Imperial College, London, UK.

No abstract available

Conflict of interest statement

Conflict of interest: Disclosures can be found alongside this article at erj.ersjournals.com

Home monitoring improves endpoint efficiency in idiopathic pulmonary fibrosis.
Johannson KA, Vittinghoff E, Morisset J, Lee JS, Balmes JR, Collard HR. Johannson KA, et al. Eur Respir J. 2017 Jul 5;50(1):1602406. doi: 10.1183/13993003.02406-2016. Print 2017 Jul. Eur Respir J. 2017. PMID: 28679608 Free PMC article.